http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-100844477-B1

Outgoing Links

Predicate Object
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2300-00
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K33-243
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-513
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4412
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-53
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-132
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-44
filingDate 2005-06-02-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 2008-07-07-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationDate 2008-07-07-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber KR-100844477-B1
titleOfInvention Anti-tumor effect enhancers, anti-tumor agents and cancer treatment methods
abstract A therapeutically effective amount of tegapur, containing an effective amount of cis-oxalate (1R, 2R-diaminocyclohexane) platinum (II) as an active ingredient, an effective amount of anti-tumor effect-enhancing gimeracil, and an effective amount of odor for suppressing side effects Antitumor effect enhancers that enhance the antitumor activity of antitumor agents containing terasil potassium; A method for treating cancer, comprising administering to the mammal an effective amount of cis-oxalate (1R, 2R-diaminocyclohexane) platinum (II) in order to enhance the antitumor agent and antitumor effect. Two or more separate components each comprising, alone or in any combination, an active ingredient consisting of tegapur, gimeracil, potassium terrasil, and cis-oxalate (1R, 2R-diaminocyclohexane) platinum (II) An anti-tumor agent and kit in the form of a formulation consisting of a formulation or in the form of a formulation comprising all active ingredients.n n n Tegapur, gimeracil, oterasyl potassium, antitumor effect enhancer, cis-oxalate platinum, cancer treatment method, antitumor agent, kit
priorityDate 2004-06-09-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6602870-B2
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID414856775
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID72210102
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID62825
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID46173707
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID288216
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419530516
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID451905405
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5386
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID454411087
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID57503849
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID137231040
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419485703
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID414858464
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID62326
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID159483528
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419583147
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID412438449
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID19800730
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6857599
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID448301271
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID428487434
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID23939
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID105166
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID415133005
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419494593
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID1133
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID4604
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5462222
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID449571706
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID54679224
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID2723920
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559508
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID450734708
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID415731140
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID408122650
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID479307
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID60953
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID426276733
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419504160
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458431511

Total number of triples: 58.